Biopharma Business

Tag "Botox"

Data Supports Advancement of Botox as Depression Treatment

Allergan plc, a global pharmaceutical company announced topline data from a phase II study with major depressive disorder (MDD). The study evaluated the efficacy, safety and tolerability of a single administration

Read Full Article

Dublin-headquartered Allergan to buy Zeltiq Aesthetics for $2.48bn

Botox maker Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion (€2.34 billion), adding muscle to its line-up of products used to fight fat and

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here